摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-2-phenoxy-1-phenylethanol | 247041-12-9

中文名称
——
中文别名
——
英文名称
(S)-2-phenoxy-1-phenylethanol
英文别名
(S)-2-phenoxy-1-phenylethan-1-ol;(1S)-2-phenoxy-1-phenylethanol
(S)-2-phenoxy-1-phenylethanol化学式
CAS
247041-12-9
化学式
C14H14O2
mdl
——
分子量
214.264
InChiKey
GSBICRJXEDSPTE-CQSZACIVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    58-60 °C(Solv: ethyl acetate (141-78-6); ligroine (8032-32-4))
  • 沸点:
    371.9±30.0 °C(Predicted)
  • 密度:
    1.134±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    光学活性美西律类似物作为电压门控Na(+)通道的立体选择性阻滞剂。
    摘要:
    合成了旋光美西律类似物,并在体外评估为骨骼肌钠通道的使用依赖性阻断剂。美西律类似物是通过用苯基取代美西律[1-(2,6-二甲基苯氧基)丙-2-胺]的立体构型中心上的甲基或修饰苯氧基部分(通过除去一个或两个)来获得的甲基,或引入氯原子),或两者兼而有之。电压钳记录表明,无论芳氧基部分的取代方式如何,所有在立体中心(3a-f)上带有苯基的化合物在滋补和相阻方面均比美西律更具活性。该观察结果与美西律的观察结果相反,在美西律中,从芳氧基部分除去两个甲基均导致效力显着降低。最有效的同类物,(R)-2-(2-甲基苯氧基)-1-苯基乙胺[[R] -3b],在产生补品阻滞(即还原)方面的效力比(R)-美西律高27倍化合物在静止状态下钠电流峰值的变化。(R)-3b保持了与使用有关的行为,在高频率刺激(阶段性阻滞)下的效用提高了23倍。尽管用美西律观察到了什么,但立体选择性在相阻条件下保持不变。立体选择性指数通常较低,范围为1-4,但除了2
    DOI:
    10.1021/jm030865y
  • 作为产物:
    描述:
    (±)-2-氯-1-苯基乙醇 在 sodium hydride 、 sodium hydroxide 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 26.17h, 生成 (S)-2-phenoxy-1-phenylethanol
    参考文献:
    名称:
    螺硼酸酯催化硼烷还原 2-卤代酮制备手性环氧化物:在光学纯 1,2-羟基醚和 1,2-叠氮醇合成中的应用
    摘要:
    描述了以 10% 螺氨基硼酸酯1作为催化剂,对映选择性硼烷介导的多种 2-卤代酮的还原反应。通过 2-卤代醇的简单基础处理,可以高产率和优异的对映体纯度(高达 99% ee)获得光学活性环氧化物。在不同的反应条件下研究了环氧乙烷与酚盐或叠氮化钠的开环,得到具有优异对映选择性 (99% ee) 和良好至高化学收率的非外消旋 1,2-羟基醚和 1,2-叠氮醇。
    DOI:
    10.1021/jo102294j
点击查看最新优质反应信息

文献信息

  • Application of Tethered Ruthenium Catalysts to Asymmetric Hydrogenation of Ketones, and the Selective Hydrogenation of Aldehydes
    作者:Katherine E. Jolley、Antonio Zanotti‐Gerosa、Fred Hancock、Alan Dyke、Damian M. Grainger、Jonathan A. Medlock、Hans G. Nedden、Jacques J. M. Le Paih、Stephen J. Roseblade、Andreas Seger、Vilvanathan Sivakumar、Ivan Prokes、David J. Morris、Martin Wills
    DOI:10.1002/adsc.201200362
    日期:2012.9.17
    An improved method for the synthesis of tethered ruthenium(II) complexes of monosulfonylated diamines is described, together with their application to the hydrogenation of ketones and aldehydes. The complexes were applied directly, in their chloride form, to asymmetric ketone hydrogenation, to give products in excess of 99% ee in the best cases, using 30 bar of hydrogen at 60 °C, and to the selective
    描述了一种改进的合成方法,用于合成单磺酰化二胺的束缚钌(II)配合物,以及它们在酮和醛加氢中的应用。将络合物以氯化物形式直接用于不对称酮的氢化反应,在最佳情况下,在60°C的条件下使用30 bar氢气,可提供超过99%ee的产物,并选择性还原醛,而不是其他官能团。组。
  • Synthesis of Enantiomerically Pure and Racemic Benzyl-Tethered Ru(II)/TsDPEN Complexes by Direct Arene Substitution: Further Complexes and Applications
    作者:Rina Soni、Katherine E. Jolley、Silvia Gosiewska、Guy J. Clarkson、Zhijia Fang、Thomas H. Hall、Ben N. Treloar、Richard C. Knighton、Martin Wills
    DOI:10.1021/acs.organomet.7b00731
    日期:2018.1.8
    The use of a direct arene-exchange method for the synthesis of benzyl-tethered arene/Ru/TsDPEN complexes for use in asymmetric transfer hydrogenation is reported. A series of complexes tethered through a three-carbon linear chain was also prepared. The arene-exchange approach significantly simplifies the synthetic approach to this class of catalyst and permits the ready formation of modified analogues
    据报道,使用直接的芳烃交换方法来合成用于不对称转移氢化的苄基系烃芳烃/ Ru / TsDPEN配合物。还制备了通过三碳线性链束缚的一系列配合物。芳烃交换方法极大地简化了这类催化剂的合成方法,并易于形成修饰的类似物。该方法还提供了外消旋催化剂的途径,用于通过氢或转移氢化进行的一般还原。
  • Further ‘tethered’ Ru(II) catalysts for asymmetric transfer hydrogenation (ATH) of ketones; the use of a benzylic linker and a cyclohexyldiamine ligand
    作者:Jose E.D. Martins、David J. Morris、Bhavana Tripathi、Martin Wills
    DOI:10.1016/j.jorganchem.2008.08.026
    日期:2008.11
    asymmetric transfer hydrogenation (ATH) of ketones is described. In the case of 4, the novelty lies in the use of a benzyl tethering group between the asymmetric ligand part (TsDPEN) and the η6-arene ring, which increases the complex rigidity. For 5, the use of a cyclohexyldiamine as a chiral ligand is described for the first time. In the ATH of ketones in formic acid/triethylamine, alcohols with ees
    描述了用于酮的不对称转移氢化(ATH)的两种新型Ru(II)催化剂的合成和表征。在的情况下4,新颖性在于在不对称配体部分(TsDPEN)和η之间使用苄束缚基团的6 -arene环,这增加了复杂的刚性。对于5,首次描述了使用环己基二胺作为手性配体。在甲酸/三乙胺中的酮的ATH中,形成了ee高达97%的醇。
  • [EN] CATALYST AND PROCESS FOR SYNTHESISING THE SAME<br/>[FR] CATALYSEUR ET SON PROCÉDÉ DE SYNTHÈSE
    申请人:UNIV WARWICK
    公开号:WO2014068331A1
    公开(公告)日:2014-05-08
    The invention relates to a method for synthesising tethered ruthenium catalysts and novel tethered ruthenium catalysts obtainable by this methods. The method involves carrying out an "arene swapping" reaction avoiding the requirement to use complicated techniques making use of unreliable Birch reductions and unstable cyclodienyl intermediates.
    这项发明涉及一种合成系列钯催化剂的方法,以及通过这种方法可获得的新型系列钯催化剂。该方法涉及进行“芳烃交换”反应,避免使用复杂技术,而不使用不可靠的Birch还原和不稳定的环二烯基中间体。
  • [EN] CATALYSTS<br/>[FR] CATALYSEURS
    申请人:GOLDENKEYS HIGH TECH MAT CO LTD
    公开号:WO2020240178A1
    公开(公告)日:2020-12-03
    A compound, e.g. a diamine ligand, represented by the following general formula (1): (Formula (1)) wherein each * represents an asymmetric carbon atom; X represents a group selected from one of an ester (e.g. a t-butyl ester); a thioester; an amide; a heterocyclic moiety (e.g. a five-membered heterocyclic ring) comprising one or more of O, S, Se, and/or P (e.g. a furan, a tetrahydrofuran, a thiophene, an isoxazole, a bromo-furan, or a thiazole); a moiety (e.g. a five-membered heterocyclic ring) comprising a nitrogen atom, wherein the nitrogen atom is protected with a protecting group containing an electron-withdrawing group, preferably the protecting group is selected from one of a carbamate protecting group, an amide protecting group, an aryl sulphonamide protecting group, or an alkyl sulphonamide protecting group; and optionally X may additionally comprise a solid support, e.g. a polymeric or a silica particle; Y represents or is CtT'T'' where 't' is 0 or 1 and when 't' is 1 T' and T'' may individually represent a substituent, e.g. if t is 1, T' and/or T'' may each be hydrogen or deuterium atom, or a halogen atom; for example, Y may represent a carbon atom comprising two further substituents; Z represents a hydrogen atom or a deuterium atom; R1 represents an alkyl group (e.g. a functionalised alkyl group) preferably having between 1 to 100 carbon atoms, for example, between 1 to 30 carbon atoms (e.g. 1 to 20 carbon atoms, or 1 to 10 carbon atoms), a halogenated alkyl group preferably having between 1 to 100 carbon atoms (e.g. CF3), for example, between 1 to 30 carbon atoms (e.g. 1 to 20 carbon atoms, or 1 to 10 carbon atoms), an aryl group preferably having between 5 to 100 carbon atoms, e.g. 6 to 30 carbon atoms and optionally having one or more substituents selected from alkyl groups preferably having 1 to 100 carbon atoms, e.g. 1 to 10 carbon atoms, halogenated alkyl groups preferably having 1 to 100 carbon atoms, e.g. 1 to 10 carbon atoms, and/or halogen atoms; or R1 represents a solid support, e.g. a silica particle or a polymeric particle; R2 and R3 each independently represent a group selected from alkyl groups preferably having between 1 to 100 carbon atoms, for example 1 to 20 carbon atoms (e.g. 1 to 10 carbon atoms), aryl groups (e.g. phenyl groups), and cycloalkyl groups preferably having 3 to 8 carbon atoms, the aryl group or phenyl group optionally having one or more substituents selected from alkyl groups preferably having between 1 to 100 carbon atoms, e.g. between 1 to 20 carbon atoms (e.g. 1 to 10 carbon atoms), alkoxy groups preferably having between 1 to 100 carbon atoms, for example, between 1 to 20 carbon atoms (e.g. 1 to 10 carbon atoms), and halogen atoms, and each hydrogen atom of the cycloalkyl groups being optionally replaced by an alkyl group preferably having between 1 to 100 carbon atoms, e.g. 1 to 20 carbon atoms (e.g. 1 to 10 carbon atoms), or R1 represents a polyethylene glycol (PEG) moiety having the formula C2nH4n+2On+1 wherein n is an integer between 1 and 100; or R2 and R3 form a ring together with carbon atoms to which R2 and R3 are bonded; R4 represents a hydrogen atom or a deuterium atom.
    一个化合物,例如一种二胺配体,由以下一般式(1)表示:(公式(1))其中每个*代表一个不对称碳原子;X代表从酯(例如叔丁基酯)中选择的一个基团;硫酯;酰胺;一个杂环基团(例如一个含有O、S、Se和/或P的五元杂环环);一个含有氮原子的基团,其中氮原子被含有电子吸引基团的保护基团保护,优选的保护基团从碳酸酯保护基团、酰胺保护基团、芳基磺酰胺保护基团或烷基磺酰胺保护基团中选择;可选地,X还可以包括固体支撑,例如聚合物或二氧化硅颗粒;Y代表或是CtT'T'',其中't'为0或1,当't'为1时,T'和T''可以分别代表一个取代基,例如,如果t为1,T'和/或T''可以分别是氢或氘原子,或卤原子;例如,Y可以代表一个包含两个进一步取代基的碳原子;Z代表氢原子或氘原子;R1代表一个烷基基团(例如,一个官能化烷基基团),优选地具有1到100个碳原子,例如,具有1到30个碳原子(例如,1到20个碳原子,或1到10个碳原子),一种卤代烷基基团,优选地具有1到100个碳原子(例如CF3),例如,具有1到30个碳原子(例如,1到20个碳原子,或1到10个碳原子),一种芳基基团,优选地具有5到100个碳原子,例如6到30个碳原子,并且可选地具有一个或多个取代基,所述取代基从烷基基团中选择,优选地具有1到100个碳原子,例如,1到10个碳原子,卤代烷基基团,优选地具有1到100个碳原子,例如,1到10个碳原子,和/或卤原子;或R1代表固体支撑,例如二氧化硅颗粒或聚合物颗粒;R2和R3各自独立地代表从烷基基团中选择的一个基团,优选地具有1到100个碳原子,例如1到20个碳原子(例如1到10个碳原子),芳基基团(例如苯基基团)和环烷基基团,优选地具有3到8个碳原子,所述芳基基团或苯基基团可选地具有一个或多个取代基,所述取代基从烷基基团中选择,优选地具有1到100个碳原子,例如,1到20个碳原子(例如,1到10个碳原子),烷氧基基团,优选地具有1到100个碳原子,例如,1到20个碳原子(例如,1到10个碳原子),和卤原子,所述环烷基基团的每个氢原子可选地被烷基基团替换,优选地具有1到100个碳原子,例如,1到20个碳原子(例如,1到10个碳原子),或R1代表具有公式C2nH4n+2On+1的聚乙二醇(PEG)基团,其中n是1到100之间的整数;或R2和R3与R2和R3结合的碳原子一起形成一个环;R4代表氢原子或氘原子。
查看更多